Acetazolamide is a prescription medication that blocks an enzyme called carbonic anhydrase, which plays a key role in how your body manages fluid, acid-base balance, and carbon dioxide. That single mechanism makes it useful across a surprisingly wide range of conditions, from altitude sickness and glaucoma to heart failure and certain breathing disorders during sleep.
How Acetazolamide Works
Carbonic anhydrase is an enzyme found in your kidneys, eyes, brain, and blood cells. It helps convert carbon dioxide and water into bicarbonate, a molecule your body uses to regulate its pH. When acetazolamide blocks this enzyme, bicarbonate builds up in your urine instead of being reabsorbed into your blood. The result is a mild, controlled shift toward acidity in your bloodstream.
That shift matters because it changes how your body breathes, how much fluid it retains, and how much pressure builds in spaces like your eyes or skull. The drug is taken orally, reaches its peak effect in about 2 to 4 hours, and is eliminated entirely through the kidneys without being broken down by the liver first.
Preventing and Treating Altitude Sickness
This is probably the best-known use of acetazolamide. When you ascend quickly to high elevations, the lower oxygen levels cause you to breathe faster, which blows off too much carbon dioxide and makes your blood overly alkaline. That alkaline shift actually limits how aggressively your body can respond to low oxygen, creating a catch-22 that leads to headaches, nausea, fatigue, and poor sleep.
Acetazolamide breaks the cycle by forcing your kidneys to dump bicarbonate, nudging your blood back toward a slightly acidic state. This lets your respiratory system respond more fully to the low-oxygen environment. According to the CDC, acclimatization that normally takes 3 to 5 days can happen in roughly one day with the drug. It also improves sleep quality at altitude by stabilizing breathing patterns overnight through its effects on the carotid body, a small cluster of cells in the neck that senses blood chemistry.
The standard preventive dose is 125 mg twice a day (or 250 mg twice daily if you weigh over 100 kg), starting the day before you ascend and continuing for the first two days at altitude, or longer if you keep climbing higher.
Lowering Eye Pressure in Glaucoma
In the eye, carbonic anhydrase helps produce aqueous humor, the fluid that fills the front chamber. When acetazolamide inhibits this enzyme, the eye produces less fluid, and intraocular pressure drops. This makes it a treatment option for glaucoma, where elevated pressure gradually damages the optic nerve and can lead to vision loss. It’s typically used when eye drops alone aren’t controlling pressure well enough, or as a short-term bridge before surgery.
Reducing Pressure Inside the Skull
Idiopathic intracranial hypertension (sometimes called pseudotumor cerebri) is a condition where cerebrospinal fluid pressure rises for no clear structural reason, causing severe headaches and threatening vision. Acetazolamide reduces the production of cerebrospinal fluid through the same enzyme-blocking mechanism it uses elsewhere in the body.
A major trial published in JAMA tested the drug in patients with mild visual loss from this condition. Participants on acetazolamide showed roughly twice the improvement in visual field measurements compared to the placebo group, and the swelling of their optic nerves (papilledema) decreased significantly more. Doses in that trial started at a moderate level and were increased weekly based on tolerance, sometimes reaching much higher daily amounts than those used for altitude sickness.
Stabilizing Breathing in Central Sleep Apnea
Central sleep apnea is different from the more common obstructive type. Instead of a physical airway blockage, the brain temporarily stops sending signals to breathe. This often happens because of instability in how sensitive the brain is to carbon dioxide levels. Small fluctuations trigger a cycle of over-breathing followed by complete pauses.
Acetazolamide helps by lowering the “apneic threshold,” the carbon dioxide level at which the brain decides to stop sending breathing signals. By creating a mild metabolic acidosis, it keeps respiratory drive more consistent throughout the night. It also reduces the brain’s overreaction to small carbon dioxide swings, smoothing out the unstable breathing pattern that defines the condition.
Boosting Diuretic Therapy in Heart Failure
When people are hospitalized with acute heart failure, the primary goal is removing excess fluid that’s congesting the lungs and other tissues. Loop diuretics are the first-line treatment, but many patients develop resistance to them. Acetazolamide works on a different part of the kidney than loop diuretics do, so adding it can overcome that resistance.
The ADVOR trial, a large study of this approach, found that adding intravenous acetazolamide to standard loop diuretic therapy improved successful fluid removal at 3 days by nearly 12 percentage points. The number needed to treat was fewer than 9, meaning for roughly every 9 patients who received the combination, one additional patient achieved adequate decongestion who wouldn’t have otherwise. Importantly, the trial found no significant increase in dangerous side effects like low potassium or kidney damage during the treatment period. Based on these results, acetazolamide has emerged as a reasonable first-choice add-on when loop diuretics alone aren’t enough.
Seizure Management
Acetazolamide has a long history as an add-on treatment for certain types of epilepsy. It’s sometimes used for catamenial epilepsy, a pattern where seizures cluster around menstruation due to hormonal shifts affecting brain excitability. In this context, acetazolamide may be taken in a pulsed fashion, only during the vulnerable days of the cycle. However, the evidence base here is notably thin. A Cochrane review found no randomized controlled trials for acetazolamide or other non-hormonal treatments in catamenial epilepsy, so its use is based largely on clinical experience rather than rigorous trial data.
Common Side Effects
The most frequently noticed side effect is paresthesia, a tingling or “pins and needles” sensation in your fingers, toes, or lips. This is a direct consequence of the drug’s mechanism and happens to a large proportion of people who take it. For altitude sickness prevention, the lower 125 mg dose was specifically chosen to minimize this effect while still working effectively.
Because acetazolamide forces your kidneys to excrete more bicarbonate, it can cause a measurable metabolic acidosis and throw off electrolyte levels, particularly potassium and sodium. You may also notice increased urination, especially in the first day or two. Some people experience taste changes, particularly with carbonated drinks, which can taste flat or metallic. Fatigue, nausea, and loss of appetite occur in some users.
Sulfa Allergy and Acetazolamide
Acetazolamide is technically a sulfonamide compound, which raises a common concern for people with sulfa allergies. But the structure that causes allergic reactions to sulfa antibiotics is a specific chemical feature (an amine group at a particular position on the molecule) that acetazolamide does not share. There is no clinical evidence of cross-reactivity between sulfonamide antibiotics and non-antibiotic sulfonamides like acetazolamide. That said, if you’ve had a severe allergic reaction to any sulfa drug, your prescriber will want to discuss the specifics of your reaction before starting you on it.